Adrenal androgens and overall survival (OS) in men with castration-resistant prostate cancer (CRPC) treated with enzalutamide without (ENZ) or with abiraterone and prednisone (ENZ/AAP) (Alliance) Meeting Abstract

  

Authors:	Sharifi, N.; Kim, H.; Alyamani, M.; Diaz, R.; Beltran, H.; Armstrong, A. J.; Morris, M. J.; Halabi, S.; Ryan, C. J.
Abstract Title:	Adrenal androgens and overall survival (OS) in men with castration-resistant prostate cancer (CRPC) treated with enzalutamide without (ENZ) or with abiraterone and prednisone (ENZ/AAP) (Alliance)
Meeting Title:	2025 ASCO Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	5 Suppl.
Meeting Dates:	2025 Feb 13-15
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-02-01
Language:	English
ACCESSION:	WOS:001454810300007
DOI:	10.1200/JCO.2025.43.5_suppl.230
PROVIDER:	wos
Notes:	Meeting Abstract: 230 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/225287